Delivery Order SPE2DB24D2217-SPE2DB25FJXEP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,827.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,155.08 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). The award, issued on June 27, 2025, with an ultimate completion date of June 30, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,431.30 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This contract, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract valued at $13,939.62. The delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $14,787.00. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count) under a firm fixed-price contract valued at $5,310.09. The award, announced on August 29, 2025, represents a competitively awarded, non-set-aside delivery order with an ultimate completion date of September 2, 2025. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania, leveraging its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,923.39 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count supply) on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract valued at $27,772.39. This competitively awarded, non-set-aside delivery order was issued on April 21, 2025, with an ultimate completion date of April 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. This non-set-aside award, issued on August 21, 2025, carries a ceiling value of $9,966.92 and is scheduled for completion by August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,282.20 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price procurement with no set-aside designation, indicating the award was competitively available. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DB24D2217Indefinite Delivery Contract
- SPE2DB24D2217-SPE2DB25FJXEPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract valued at $4,833.56. The award was made on June 26, 2025, with an ultimate completion date of June 27, 2025, and represents a competitively awarded, non-set-aside procurement. Performance of this delivery order will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen demonstrates significant capability in fulfilling Defense Department healthcare supply requirements across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 6/26/25 |